Plasmodium falciparum Immune Escape, Antimalarial Drug Resistance and Diagnostic Evasion: Adaptive Outcomes under Host and Programmatic Selection Pressure
Ademola E. Alaba *
Molecular Parasitology and Genetics Unit, Department of Microbiology and Biotechnology, Ajayi Crowther University, Oyo, Oyo State, Nigeria.
Ayoola O. Afolabi
Department of Microbiology and Biotechnology, Ajayi Crowther University, Oyo, Oyo State, Nigeria.
John O. Olayiwola
Public Health and Infectious Diseases Unit, Department of Microbiology and Biotechnology, Ajayi Crowther University, Oyo, Oyo State, Nigeria.
Moses S. Afariogun
Department of Microbiology and Biotechnology, Ajayi Crowther University, Oyo, Oyo State, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Plasmodium falciparum remains the leading cause of malaria mortality in sub-Saharan Africa despite repeated host immune exposure and sustained intervention pressure.
Objectives: This narrative critical review examines molecular and cellular mechanisms by which P. falciparum evades or modulates host immunity and evaluates the translational consequences for vaccines, diagnostics, antimalarial drugs, and surveillance, with particular attention to African and Nigerian contexts.
Methods: Targeted searches of PubMed/MEDLINE, Google Scholar, WHO publications, MalariaGEN resources, and reference lists of major reviews, clinical trials, and surveillance studies were used. Priority was given to peer-reviewed primary research, systematic reviews, clinical trials, genomic-surveillance reports, and WHO policy documents published from 2009 to 2026, while older foundational papers were retained where required for mechanistic context.
Results: Immune escape, antimalarial drug resistance, and diagnostic evasion by pfhrp2/pfhrp3-deleted parasites are interpreted as mechanistically distinct but evolutionarily analogous adaptive outcomes under host or programmatic selection pressure. Antigenic variation, antigenic polymorphism, intracellular residence, cytoadherence, atypical dendritic-cell activation, atypical memory B-cell expansion, T-cell regulation, natural-killer-cell modulation, and complement evasion are reviewed with attention to evidence strength and uncertainty. The independent emergence of kelch13-associated artemisinin partial-resistance markers in Africa and the spread of pfhrp2/pfhrp3 deletions are discussed as operationally important examples of population-level adaptation.
Conclusions: Durable malaria control will require integrated responses across vaccine design, drug stewardship, diagnostic policy, and genomic surveillance. Six prioritized knowledge gaps are identified, and recommendations are proposed for research and public-health implementation in African high-burden settings.
Keywords: Plasmodium falciparum, immune escape, antigenic variation, atypical memory B cells, artemisinin partial resistance, kelch13, pfhrp2/pfhrp3 deletion, malaria vaccine